Q

uniQure NV

QURE

7.51000
USD
-0.145
(-1.89%)
مفتوح الان
حجم التداول
8,186
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
312,151,738
أصول ذات صلة
A
ALNY
31.19
(13.13%)
268.66 USD
B
BIIB
-2.500
(-1.17%)
210.710 USD
B
BLUE
-0.06000
(-5.26%)
1.08000 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
GILD
0.470
(0.62%)
76.510 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
S
SGMO
-0.09690
(-12.11%)
0.70340 USD
الأخبار المقالات

العنوان: uniQure NV

القطاع: Healthcare
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.